Apixaban-Induced Hemopericardium in a Post-TAVR Patient: A Case Report Highlighting Diagnostic and Management Challenges

Rabia Latif; Mohammed Aloqaily; Alexander Rabadi; Khurram Arshad; Aaron I. Kurian; Islam Obeidat; Ibrahim Al-Sanouri

doi:10.12659/AJCR.944173

26 July 2024 : Case report USA

Apixaban-Induced Hemopericardium in a Post-TAVR Patient: A Case Report Highlighting Diagnostic and Management Challenges

Unusual clinical course, Challenging differential diagnosis, Unusual or unexpected effect of treatment, Diagnostic / therapeutic accidents, Adverse events of drug therapy, Clinical situation which can not be reproduced for ethical reasons

Rabia Latif^12ABCDEFG, Mohammed Aloqaily^3ABCD, Alexander Rabadi^12ABCDEF, Khurram Arshad^4ABCDEFG*, Aaron I. Kurian^12ABCD, Islam Obeidat^12ABCD, Ibrahim Al-Sanouri^5ABCDEF

DOI: 10.12659/AJCR.944173

Am J Case Rep 2024; 25:e944173

Authors information Article notes Copyright and License information

Introduction Case Report Discussion Conclusions References:

View HTML version

Figure 2. (A) Chest X-ray prior to echocardiography, (B) Chest X-ray on the day of transfer.

Back to the Article

Apixaban-Induced Hemopericardium in a Post-TAVR Patient: A Case Report Highlighting Diagnostic and Management Challenges

Your Privacy